Bladder Infection In Females - Cefpodoxime Disappoints

According to a study published in the February 8 issue of JAMA, cefpodoxime, an antibiotic used as a short-term therapy in women with uncomplicated bladder infection (cystitis), failed to meet criteria for non-inferiority in comparison to ciprofloxacin. There have been concerns that ciprofloxacin, classed as a fluoroquinolone antibiotic, is overused, resulting in an increase in [...]

Proton Pump Inhibitors Linked to C difficile Diarrhea

The FDA is warning that PPIs may be associated with a higher risk for Clostridium difficile-associated diarrhea, a persistent illness that comes with abdominal pain and fever. News Alerts

Why Don’t Women Take Care of Their Health, Really?

A study tries to determine whether it’s knowledge, finances, or a deficit of “self-nurturing” behaviors that keeps women from taking care of their health. Medscape Nurses

Physical Punishment Harms Children’s Long-Term Development

Physical punishment, including spanking and slapping, can damage a child’s long-term development and increase the risk of aggression, antisocial behavior, and mental illness, a new analysis shows. Medscape Medical News

Obama Administration Makes Greater Investment in Alzheimer’s

The US government today announced a commitment of $156 million over the course of the next 2 years to fight Alzheimer’s disease. Medscape Medical News

Panel: Hospitals Should Consider Mandatory Flu Shots

WASHINGTON (MedPage Today) — If hospitals and clinics can’t get 90% of their employees to get an annual flu shot, they should “strongly consider” making the vaccine mandatory, a federal vaccines panel has voted.

‘Untreatable’ Gonorrhea Looms, CDC Warns (with audio)

(MedPage Today) — Gonorrhea is putting up increasing resistance to the last antibiotic class highly effective against it, the CDC has again warned.

Drugs Not Equal Against Bladder Infection (CME/CE)

(MedPage Today) — For uncomplicated bladder infections, cefpodoxime (Vantin) may may not be a good antibiotic alternative to the fluoroquinolone ciprofloxacin, a randomized trial suggested.

FDA Panel Turns Down Bone Drug in Prostate Ca

WASHINGTON (MedPage Today) — An FDA panel has voted 12-1 against expanding the indication for Amgen’s denosumab (Xgeva) to prevent the spread of prostate cancer to the bones in men with a high-risk form of the disease.

No-Combing Lice Lotion Gets FDA Go-Ahead

WASHINGTON (MedPage Today) — The FDA has approved the topical ivermectin 0.5% lotion (Sklice) for the treatment of head lice in patients 6 months and older.